Foster Victor Wealth Advisors LLC Has $7.13 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Foster Victor Wealth Advisors LLC raised its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 3.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,138 shares of the company’s stock after buying an additional 1,593 shares during the period. Foster Victor Wealth Advisors LLC’s holdings in Procter & Gamble were worth $7,133,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble in the 2nd quarter worth $29,000. Ruedi Wealth Management Inc. boosted its stake in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new position in Procter & Gamble during the 2nd quarter worth $34,000. Finally, Quest Partners LLC bought a new stake in Procter & Gamble in the 2nd quarter worth about $36,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $173.61 on Wednesday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94. The company’s 50-day moving average price is $171.68 and its 200-day moving average price is $166.96. The company has a market cap of $409.74 billion, a PE ratio of 28.37, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.37 earnings per share. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.32%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Wall Street Analyst Weigh In

PG has been the topic of several research reports. Stifel Nicolaus boosted their target price on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Royal Bank of Canada raised their price target on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a report on Wednesday, July 31st. Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Piper Sandler assumed coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Finally, Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $176.21.

Read Our Latest Analysis on PG

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the transaction, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 383,194 shares of company stock worth $65,140,718. Insiders own 0.17% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.